logo
logo
Sign in

The biomaterials segment to manifest the highest CAGR through 2030

avatar
Ashish Gujrathi
The biomaterials segment to manifest the highest CAGR through 2030

High prevalence of chronic disease rise in global geriatric population and increase in healthcare expenditure are expected to propel the growth of the global powered surgical instrument market. 


Rise in prevalence of neurological & epidemic disorders and surge in geriatric population that need nerve repair and regeneration therapy drive the global nerve repair and regeneration market. However, high cost associated with neurostimulator devices and lack of skilled professionals hinder the market growth. On the contrary, surge in awareness among people and increase in expenditure on healthcare would open new opportunities in the future.



Covid-19 scenario


  • The Covid-19 pandemic negatively affected the market. Hospitals and healthcare services reduced owing to social distancing measures taken by the government.


  • Moreover, the pandemic severely affected the global economy and affected the functioning of general hospital care for non-Covid-19 patients. As several hospitals were closed due to lockdown, the demand for nerve repair and regeneration procedures experienced a decline.


The biomaterials segment to manifest the highest CAGR through 2030


By product, the biomaterials segment is expected to showcase the highest CAGR of 7.0% during the forecast period, due to increase in target population base and increase in awareness among patients. However, the neuromodulation surgery devices segment held the largest share in 2020, contributing to more than two-thirds of the global nerve repair and regeneration market, owing to increase in consumer awareness about nerve repair and advent of innovative technologies in the healthcare sector.


The neuromodulation surgery segment held the lion's share


By surgery, the neuromodulation surgery segment dominated the market in terms of revenue, accounting for nearly half of the global nerve repair and regeneration market in 2020, due to rise in number of product approvals. However, the direct neuropathy segment would portray the highest CAGR of 7.6% during the forecast period, due to surge in awareness of benefits of using external neuromodulators.


North America held the largest share


By region, the global nerve repair and regeneration market across North America held the lion's share in 2020, contributing to around two-fifths of the market, due to increase in the prevalence of neurodegenerative & neurodevelopmental diseases, stroke, and traumatic brain injuries coupled with increase in adoption of advanced healthcare infrastructure. However, the market across Asia-Pacific is projected to manifest the highest CAGR of 7.5% during the forecast period, owing to rise in awareness among patient, supportive government initiatives, and presence of unmet medical needs, and advent of innovative technologies.


Key market players


  • Abbott Laboratories
  • Integra Lifesciences Corporation
  • Boston scientific Inc.
  • Axogenic
  • Medtronic plc
  • Checkpoint Surgical
  • Stryker Corporation
  • Synovis Micro Companies Alliance
  • Polyganics
  • OrthoMed, Inc.


collect
0
avatar
Ashish Gujrathi
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more